Ablation Devices Market by Technology (Thermal [Electrical, Radiation, Radiofrequency, Light, Ultrasound, Microwave, and Hydrothermal Ablation] and Non-Thermal Ablation [Cryoablation and Hydromechanical Ablation]), Application (Cancer, Cardiovascular, Ophthalmology, Gynecology, Urology, and Orthopedics), Function (Automated/Robotic and Conventional Ablation Devices) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Ablation is a minimal invasive medical procedure to destroy the abnormal tissues. It is performed with the help of probes that can be inserted through the skin or by using catheters that can be inserted through an artery or energy beams to reach the area that needs to be treated. An imaging technique such as MRI or rotational angiography is used to guide the probes or catheters to the site during ablation.
The world ablation device market is estimated to grow from $3,047 million in 2015 to $6,658 million by 2022 at a CAGR of 11.7% from 2016 to 2022. This can be attributed to the increase in demand for minimal invasive surgeries and increase in the prevalence of patients with chronic illnesses. Other factors such as minimal damage and blood loss, and short duration are some of the factors that contribute towards the growth of this market. However, stringent government regulations and unstable reimbursement policies restrain the market growth.
By technology, the ablation devices market is broadly categorized into thermal and non-thermal technologies. Thermal technologies comprise microwave, electrical, light, radiation, ultrasound, radiofrequency, and hydrothermal technologies, and each of these are further subcategorized. Thus, electrical ablation includes electrical ablators and electronic brachytherapy, while light ablation includes cold and exicmer laser. In addition, radiation ablation is sub-categorized into brachytherapy, stereotactic radiotherapy & radiosurgery, stereotactic body radiation, image guided radiation therapy, intensity modulated radiation therapy, and proton beam therapy. While ultrasound ablation is sub-divided into high intensity focused ultrasound (HIFU), magnetic resonance imaging-guided focused ultrasound (MRI-FUS), ultrasonic surgical systems, and shock wave lithotripsy; radiofrequency ablation is sub-divided into temperature controlled, fluid cooled, and catheter manipulation systems. However, the non-thermal technology market comprises cryoablation and hydromechanical ablation, wherein Cryoablation includes tissue contact probe, cryogen spray probe, and epidermal & subcutaneous cryoablation devices.
By applications, the ablation devices market is segmented into cancer, cardiology, ophthalmology, gynecology, urology, orthopedics, and other medical conditions. On the basis of function, the market is divided into automated/robotic and conventional ablation devices. Based on procedure, the market is segmented as aesthetics-skin rejuvenation & tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser- and other energy-based therapies/ holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression & denervation, varicose veins, atrial fibrillation, tumor ablation, and others. By geography, the ablation devices market is categorized into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players. For instance, on 26th January 2016, Medtronic PLC acquired Covidien to expand their access and improve their clinical outcomes at lower cost. Moreover, this acquisition has helped Medtronic PLC to compete with Johnson & Johnson. Boston Scientific Corporation acquired Cosman Medical on July 27, 2016to improve its neuromodulation portfolio and help provide innovative solutions for chronic pain treatment.
KEY MARKET BENEFITS:
The world ablation devices market segmentation is explained below.
By Technology
The world ablation device market is estimated to grow from $3,047 million in 2015 to $6,658 million by 2022 at a CAGR of 11.7% from 2016 to 2022. This can be attributed to the increase in demand for minimal invasive surgeries and increase in the prevalence of patients with chronic illnesses. Other factors such as minimal damage and blood loss, and short duration are some of the factors that contribute towards the growth of this market. However, stringent government regulations and unstable reimbursement policies restrain the market growth.
By technology, the ablation devices market is broadly categorized into thermal and non-thermal technologies. Thermal technologies comprise microwave, electrical, light, radiation, ultrasound, radiofrequency, and hydrothermal technologies, and each of these are further subcategorized. Thus, electrical ablation includes electrical ablators and electronic brachytherapy, while light ablation includes cold and exicmer laser. In addition, radiation ablation is sub-categorized into brachytherapy, stereotactic radiotherapy & radiosurgery, stereotactic body radiation, image guided radiation therapy, intensity modulated radiation therapy, and proton beam therapy. While ultrasound ablation is sub-divided into high intensity focused ultrasound (HIFU), magnetic resonance imaging-guided focused ultrasound (MRI-FUS), ultrasonic surgical systems, and shock wave lithotripsy; radiofrequency ablation is sub-divided into temperature controlled, fluid cooled, and catheter manipulation systems. However, the non-thermal technology market comprises cryoablation and hydromechanical ablation, wherein Cryoablation includes tissue contact probe, cryogen spray probe, and epidermal & subcutaneous cryoablation devices.
By applications, the ablation devices market is segmented into cancer, cardiology, ophthalmology, gynecology, urology, orthopedics, and other medical conditions. On the basis of function, the market is divided into automated/robotic and conventional ablation devices. Based on procedure, the market is segmented as aesthetics-skin rejuvenation & tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser- and other energy-based therapies/ holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression & denervation, varicose veins, atrial fibrillation, tumor ablation, and others. By geography, the ablation devices market is categorized into North America, Europe, Asia-Pacific, and LAMEA.
The growth in competition and continuous technological advancements have led to mergers & acquisitions by major players. For instance, on 26th January 2016, Medtronic PLC acquired Covidien to expand their access and improve their clinical outcomes at lower cost. Moreover, this acquisition has helped Medtronic PLC to compete with Johnson & Johnson. Boston Scientific Corporation acquired Cosman Medical on July 27, 2016to improve its neuromodulation portfolio and help provide innovative solutions for chronic pain treatment.
KEY MARKET BENEFITS:
- Quantitative analysis of the current trends and market estimations from 2014 to 2022 is presented to identify potential market opportunities.
- The report provides an in-depth analysis of the market and total revenue generated during the forecast period.
- A detailed analysis based on applications and procedures are presented to understand the type of products in trend or would be in demand to assist in product developments and collaborations.
- Comprehensive analysis of the market drivers and constraints is provided to identify the prevailing market opportunities.
- Competitive intelligence highlights the business practices followed by leading market players across various geographies.
The world ablation devices market segmentation is explained below.
By Technology
- Thermal Ablation
- Electrical
- Electrical Ablators
- Argon Plasma/Beam Coagulator
- Irreversible Electroporation
- Electronic Brachytherapy
- Radiation
- Brachytherapy
- High-Dose-Rate Brachytherapy
- Pulsed-Dose-Rate Brachytherapy
- Permanent Seed Brachytherapy
- Stereotactic Radiotherapy & Radiosurgery
- Stereotactic Body Radiation
- Image Guided Radiation Therapy
- Intensity Modulated Radiation Therapy
- Proton Beam Therapy
- Radiofrequency
- Temperature Controlled
- Fluid Cooled
- Catheter Manipulation Systems
- Light
- Cold Lasers
- Excimer Lasers
- Ultrasound
- High Intensity Focused Ultrasound (HIFU)
- Magnetic Resonance Imaging-Guided Focused Ultrasound (MRI-FUS)
- Ultrasonic Surgical Systems
- Shock Wave Lithotripsy
- Microwave
- Hydrothermal
- Non-Thermal Ablation
- Cryoablation
- Tissue Contact Probe
- Cryogen Spray Probe
- Epidermal and Subcutaneous Cryoablation Devices
- Hydromechanical Ablation
- Cancer
- Cardiovascular
- Ophthalmology
- Gynecology
- Urology
- Orthopedics
- Others
- Automated/Robotic
- Conventional
- Aesthetics-Skin Rejuvenation and Tightening
- Aesthetics-Body Sculpting, Fat Reduction, And The Reduction in The Appearance of Cellulite
- Benign Prostatic Hyperplasia
- Transurethral Needle Ablation
- Laser and Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation Of The Prostate
- Stress Urinary Incontinence
- Menorrhagia/Endometrial Ablation
- Uterine Fibroids
- Spinal Decompression and Denervation
- Varicose Veins
- Atrial Fibrillation
- Tumor Ablation
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Republic of South Africa
- Rest of LAMEA
- The key players profiled in this report are listed below:
- St. Jude Medical, Inc.
- Medtronic PLC
- Boston Scientific Corporation
- AngioDynamics, Inc.
- AtriCure, Inc.
- Conmed Corporation
- Olympus Corporation
- Smith & Nephew PLC
- BTG plc
- Johnson & Johnson
- Accuray Incorporated
- C.R. Bard, Inc.
- Varian Medical Systems, Inc.
- Elekta AB
- Misonix, Inc.
- Hologic, Inc.
- Stryker Corporation
- EDAP TMS S.A.
- Japan Lifeline Co., Ltd.
- Halyard Health, Inc.
- Merit Medical Systems, Inc.
- Integra Lifesciences Holdings Corporation
- Abbott Laboratories
- Terumo Corporation
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE mark
3.3.3 Others
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.6.1 Patent analysis, by year
3.6.2 Patent analysis, by company
3.7 Top impacting factors
3.7.1 Drivers
3.7.1.1 Rise in the prevalence of chronic illnesses
3.7.1.2 Technological advancements
3.7.1.3 Short duration and high efficacy of the procedure
3.7.2 Restraints
3.7.2.1 Government regulations and reimbursement policies
3.7.2.2 High cost and limited awareness
3.7.3 Opportunities
3.7.3.1 Increase in the level of awareness
3.7.3.2 Untapped markets in emerging economies
CHAPTER 4 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Thermal ablation technology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Radiofrequency ablation
4.2.4.1 Market size and forecast
4.2.4.2 Temperature-controlled radiofrequency ablation devices
4.2.4.3 Market size and forecast
4.2.4.4 Fluid-cooled radiofrequency ablation
4.2.4.5 Market size and forecast
4.2.4.6 Catheter manipulation system
4.2.4.7 Market size and forecast
4.2.5 Electrical ablation
4.2.5.1 Market size and forecast
4.2.5.2 Electrical ablators
4.2.5.3 Market size and forecast
4.2.5.4 Argon plasma/beam coagulator
4.2.5.5 Market size and forecast
4.2.5.6 Irreversible electroporation
4.2.5.7 Market size and forecast
4.2.5.8 Electronic brachytherapy
4.2.5.9 Market size and forecast
4.2.6 Microwave
4.2.6.1 Market size and forecast
4.2.7 Hydrothermal ablation
4.2.7.1 Market size and forecast
4.2.8 Light ablation
4.2.8.1 Market size and forecast
4.2.8.2 Cold laser
4.2.8.3 Market size and forecast
4.2.8.4 Excimer laser
4.2.8.5 Market size and forecast
4.2.9 Radiation ablation
4.2.9.1 Market size and forecast
4.2.9.2 Brachytherapy
4.2.9.3 Market size and forecast
4.2.9.4 High-dose-rate brachytherapy
4.2.9.5 Market size and forecast
4.2.9.6 Pulsed-dose-rate brachytherapy
4.2.9.7 Market size and forecast
4.2.9.8 Permanent seed brachytherapy or low-dose-rate brachytherapy
4.2.9.9 Market size and forecast
4.2.9.10 Stereotactic radiotherapy and radiosurgery
4.2.9.11 Market size and forecast
4.2.9.12 Image-guided radiation therapy
4.2.9.13 Market size and forecast
4.2.9.14 Intensity-modulated radiation therapy
4.2.9.15 Market size and forecast
4.2.9.16 Stereotactic body radiation therapy
4.2.9.17 Market size and forecast
4.2.9.18 Proton beam therapy
4.2.9.19 Market size and forecast
4.2.10 Ultrasound ablation
4.2.10.1 Market size and forecast
4.2.10.2 High-intensity focused ultrasound
4.2.10.3 Market size and forecast
4.2.10.4 Magnetic resonance imaging guided focus ultrasound (MRI-FUS)
4.2.10.5 Market size and forecast
4.2.10.6 Ultrasonic surgical systems
4.2.10.7 Market size and forecast
4.2.10.8 Shock wave lithotripsy
4.2.10.9 Market size and forecast
4.3 Non-thermal ablation technology
4.3.1 Key market trends
4.3.2 Key growth opportunities and opportunities
4.3.3 Market size and forecast
4.3.4 Cryoablation
4.3.4.1 Market size and forecast
4.3.4.2 Tissue contact probe
4.3.4.3 Market size and forecast
4.3.4.4 Cryogen spray probe
4.3.4.5 Market size and forecast
4.3.4.6 Epidermal and subcutaneous cryoablation devices
4.3.4.7 Market size and forecast
4.3.5 Hydromechanical
4.3.5.1 Market size and forecast
CHAPTER 5 WORLD ABLATION DEVICES MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cancer
5.2.1 Market size and forecast
5.3 Cardiovascular
5.3.1 Market size and forecast
5.4 Ophthalmology
5.4.1 Market size and forecast
5.5 Gynecology
5.5.1 Market size and forecast
5.6 Urology
5.6.1 Market size and forecast
5.7 Orthopedics
5.7.1 Market size and forecast
5.8 Others
5.8.1 Market size and forecast
CHAPTER 6 WORLD ABLATION DEVICES MARKET, BY FUNCTION
6.1 Overview
6.1.1 Market size and forecast
6.2 Automated/robotic ablation devices
6.2.1 Market size and forecast
6.3 Conventional ablation devices
6.3.1 Market size and forecast
CHAPTER 7 WORLD ABLATION DEVICES MARKET, BY PROCEDURE
7.1 Overview
7.1.1 Market size and forecast
7.2 Aesthetics-skin rejuvenation and tightening
7.2.1 Market size and forecast
7.3 Aesthetics-body sculpting, fat reduction, and the minimization in the appearance of cellulite
7.3.1 Market size and forecast
7.4 Benign prostatic hyperplasia
7.4.1 Market size and forecast
7.5 Transurethral needle ablation
7.5.1 Market size and forecast
7.6 Laser and other energy-based therapies/holmium laser ablation /enucleation of the prostate
7.6.1 Market size and forecast
7.7 Stress urinary incontinence
7.7.1 Market size and forecast
7.8 Menorrhagia/endometrial ablation
7.8.1 Market size and forecast
7.9 Uterine fibroids
7.9.1 Market size and forecast
7.10 Spinal decompression and denervation
7.10.1 Market size and forecast
7.11 Varicose veins
7.11.1 Market size and forecast
7.12 Atrial fibrillation
7.12.1 Market size and forecast
7.13 Tumor ablation
7.13.1 Market size and forecast
7.14 Others
7.14.1 Market size and forecast
CHAPTER 8 WORLD ABLATION DEVICES MARKET, BY GEOGRAPHY
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 U.S. market size and forecast
8.2.5 Canada market size and forecast
8.2.6 Mexico market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany market size and forecast
8.3.5 France market size and forecast
8.3.6 UK market size and forecast
8.3.7 Italy market size and forecast
8.3.8 Spain market size and forecast
8.3.9 Russia market size and forecast
8.3.10 Rest of Europe market size and forecast
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 Japan market size and forecast
8.4.5 China market size and forecast
8.4.6 Australia market size and forecast
8.4.7 India market size and forecast
8.4.8 South Korea market size and forecast
8.4.9 Taiwan market size and forecast
8.4.10 Rest of Asia-Pacific market size and forecast
8.5 Latin America, Middle East, And Africa (LAMEA)
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Brazil market size and forecast
8.5.5 Turkey market size and forecast
8.5.6 Venezuela market size and forecast
8.5.7 Saudi Arabia market size and forecast
8.5.8 Republic of South Africa market size and forecast
8.5.9 Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Medtronic PLC
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves and developments
9.2 Johnson and Johnson
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves and developments
9.3 St. Jude Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves and developments
9.4 Boston Scientific Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves and developments
9.5 AngioDynamics, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Business performance
9.5.5 Key strategic moves and developments
9.6 AtriCure, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves and developments
9.7 Conmed Corporation
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Business performance
9.7.5 Key strategic moves and developments
9.8 Olympus Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves and developments
9.9 Smith & Nephew PLC
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves and developments
9.10 BTG plc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves and developments
Other players in the RPM market include (profiles not included in the report)
Accuray Incorporated
C.R. Bard, Inc.
Varian Medical Systems, Inc.
Elekta AB
Misonix, Inc.
Hologic, Inc.
Stryker Corporation
EDAP TMS S.A.
Japan Lifeline Co., Ltd.
Halyard Health, Inc.
Merit Medical Systems, Inc.
Integra Lifesciences Holdings Corporation
Abbott Laboratories
Terumo Corporation
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Key findings
3.2.1 Top investment pockets
3.2.2 Top winning strategies
3.3 Government regulations
3.3.1 U.S. FDA
3.3.2 Europe CE mark
3.3.3 Others
3.4 Reimbursement scenarios
3.5 Clinical trials
3.6 Patent analysis
3.6.1 Patent analysis, by year
3.6.2 Patent analysis, by company
3.7 Top impacting factors
3.7.1 Drivers
3.7.1.1 Rise in the prevalence of chronic illnesses
3.7.1.2 Technological advancements
3.7.1.3 Short duration and high efficacy of the procedure
3.7.2 Restraints
3.7.2.1 Government regulations and reimbursement policies
3.7.2.2 High cost and limited awareness
3.7.3 Opportunities
3.7.3.1 Increase in the level of awareness
3.7.3.2 Untapped markets in emerging economies
CHAPTER 4 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY
4.1 Overview
4.1.1 Market size and forecast
4.2 Thermal ablation technology
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Radiofrequency ablation
4.2.4.1 Market size and forecast
4.2.4.2 Temperature-controlled radiofrequency ablation devices
4.2.4.3 Market size and forecast
4.2.4.4 Fluid-cooled radiofrequency ablation
4.2.4.5 Market size and forecast
4.2.4.6 Catheter manipulation system
4.2.4.7 Market size and forecast
4.2.5 Electrical ablation
4.2.5.1 Market size and forecast
4.2.5.2 Electrical ablators
4.2.5.3 Market size and forecast
4.2.5.4 Argon plasma/beam coagulator
4.2.5.5 Market size and forecast
4.2.5.6 Irreversible electroporation
4.2.5.7 Market size and forecast
4.2.5.8 Electronic brachytherapy
4.2.5.9 Market size and forecast
4.2.6 Microwave
4.2.6.1 Market size and forecast
4.2.7 Hydrothermal ablation
4.2.7.1 Market size and forecast
4.2.8 Light ablation
4.2.8.1 Market size and forecast
4.2.8.2 Cold laser
4.2.8.3 Market size and forecast
4.2.8.4 Excimer laser
4.2.8.5 Market size and forecast
4.2.9 Radiation ablation
4.2.9.1 Market size and forecast
4.2.9.2 Brachytherapy
4.2.9.3 Market size and forecast
4.2.9.4 High-dose-rate brachytherapy
4.2.9.5 Market size and forecast
4.2.9.6 Pulsed-dose-rate brachytherapy
4.2.9.7 Market size and forecast
4.2.9.8 Permanent seed brachytherapy or low-dose-rate brachytherapy
4.2.9.9 Market size and forecast
4.2.9.10 Stereotactic radiotherapy and radiosurgery
4.2.9.11 Market size and forecast
4.2.9.12 Image-guided radiation therapy
4.2.9.13 Market size and forecast
4.2.9.14 Intensity-modulated radiation therapy
4.2.9.15 Market size and forecast
4.2.9.16 Stereotactic body radiation therapy
4.2.9.17 Market size and forecast
4.2.9.18 Proton beam therapy
4.2.9.19 Market size and forecast
4.2.10 Ultrasound ablation
4.2.10.1 Market size and forecast
4.2.10.2 High-intensity focused ultrasound
4.2.10.3 Market size and forecast
4.2.10.4 Magnetic resonance imaging guided focus ultrasound (MRI-FUS)
4.2.10.5 Market size and forecast
4.2.10.6 Ultrasonic surgical systems
4.2.10.7 Market size and forecast
4.2.10.8 Shock wave lithotripsy
4.2.10.9 Market size and forecast
4.3 Non-thermal ablation technology
4.3.1 Key market trends
4.3.2 Key growth opportunities and opportunities
4.3.3 Market size and forecast
4.3.4 Cryoablation
4.3.4.1 Market size and forecast
4.3.4.2 Tissue contact probe
4.3.4.3 Market size and forecast
4.3.4.4 Cryogen spray probe
4.3.4.5 Market size and forecast
4.3.4.6 Epidermal and subcutaneous cryoablation devices
4.3.4.7 Market size and forecast
4.3.5 Hydromechanical
4.3.5.1 Market size and forecast
CHAPTER 5 WORLD ABLATION DEVICES MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Cancer
5.2.1 Market size and forecast
5.3 Cardiovascular
5.3.1 Market size and forecast
5.4 Ophthalmology
5.4.1 Market size and forecast
5.5 Gynecology
5.5.1 Market size and forecast
5.6 Urology
5.6.1 Market size and forecast
5.7 Orthopedics
5.7.1 Market size and forecast
5.8 Others
5.8.1 Market size and forecast
CHAPTER 6 WORLD ABLATION DEVICES MARKET, BY FUNCTION
6.1 Overview
6.1.1 Market size and forecast
6.2 Automated/robotic ablation devices
6.2.1 Market size and forecast
6.3 Conventional ablation devices
6.3.1 Market size and forecast
CHAPTER 7 WORLD ABLATION DEVICES MARKET, BY PROCEDURE
7.1 Overview
7.1.1 Market size and forecast
7.2 Aesthetics-skin rejuvenation and tightening
7.2.1 Market size and forecast
7.3 Aesthetics-body sculpting, fat reduction, and the minimization in the appearance of cellulite
7.3.1 Market size and forecast
7.4 Benign prostatic hyperplasia
7.4.1 Market size and forecast
7.5 Transurethral needle ablation
7.5.1 Market size and forecast
7.6 Laser and other energy-based therapies/holmium laser ablation /enucleation of the prostate
7.6.1 Market size and forecast
7.7 Stress urinary incontinence
7.7.1 Market size and forecast
7.8 Menorrhagia/endometrial ablation
7.8.1 Market size and forecast
7.9 Uterine fibroids
7.9.1 Market size and forecast
7.10 Spinal decompression and denervation
7.10.1 Market size and forecast
7.11 Varicose veins
7.11.1 Market size and forecast
7.12 Atrial fibrillation
7.12.1 Market size and forecast
7.13 Tumor ablation
7.13.1 Market size and forecast
7.14 Others
7.14.1 Market size and forecast
CHAPTER 8 WORLD ABLATION DEVICES MARKET, BY GEOGRAPHY
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 U.S. market size and forecast
8.2.5 Canada market size and forecast
8.2.6 Mexico market size and forecast
8.3 Europe
8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany market size and forecast
8.3.5 France market size and forecast
8.3.6 UK market size and forecast
8.3.7 Italy market size and forecast
8.3.8 Spain market size and forecast
8.3.9 Russia market size and forecast
8.3.10 Rest of Europe market size and forecast
8.4 Asia-Pacific
8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 Japan market size and forecast
8.4.5 China market size and forecast
8.4.6 Australia market size and forecast
8.4.7 India market size and forecast
8.4.8 South Korea market size and forecast
8.4.9 Taiwan market size and forecast
8.4.10 Rest of Asia-Pacific market size and forecast
8.5 Latin America, Middle East, And Africa (LAMEA)
8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Brazil market size and forecast
8.5.5 Turkey market size and forecast
8.5.6 Venezuela market size and forecast
8.5.7 Saudi Arabia market size and forecast
8.5.8 Republic of South Africa market size and forecast
8.5.9 Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1 Medtronic PLC
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Business performance
9.1.5 Key strategic moves and developments
9.2 Johnson and Johnson
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Business performance
9.2.5 Key strategic moves and developments
9.3 St. Jude Medical, Inc.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Business performance
9.3.5 Key strategic moves and developments
9.4 Boston Scientific Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Business performance
9.4.5 Key strategic moves and developments
9.5 AngioDynamics, Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Business performance
9.5.5 Key strategic moves and developments
9.6 AtriCure, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Business performance
9.6.5 Key strategic moves and developments
9.7 Conmed Corporation
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Business performance
9.7.5 Key strategic moves and developments
9.8 Olympus Corporation
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Business performance
9.8.5 Key strategic moves and developments
9.9 Smith & Nephew PLC
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Business performance
9.9.5 Key strategic moves and developments
9.10 BTG plc
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Business performance
9.10.5 Key strategic moves and developments
Other players in the RPM market include (profiles not included in the report)
Accuray Incorporated
C.R. Bard, Inc.
Varian Medical Systems, Inc.
Elekta AB
Misonix, Inc.
Hologic, Inc.
Stryker Corporation
EDAP TMS S.A.
Japan Lifeline Co., Ltd.
Halyard Health, Inc.
Merit Medical Systems, Inc.
Integra Lifesciences Holdings Corporation
Abbott Laboratories
Terumo Corporation
LIST OF TABLES
TABLE 1 CLINICAL TRIALS, ABLATION DEVICES MARKET, 20102016
TABLE 2 PATENTS REGISTERED/APPROVED, BY COUNTRY (20102016)
TABLE 3 PATENTS REGISTERED/APPROVED, BY YEAR (20102015)
TABLE 4 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
TABLE 5 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 6 WORLD THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 7 WORLD THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 8 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 9 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 10 WORLD TEMPERATURE CONTROLLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 11 WORLD FLUID COOLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 12 WORLD FLUID COOLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 13 WORLD ELECTRICAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 14 WORLD ELECTRICAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 15 WORLD ELECTRICAL ABLATORS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 16 WORLD ELECTRICAL ABLATORS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 17 WORLD ARGON PLASMA/BEAM COAGULATOR MARKET, BY REGION, 20142022 ($MILLION)
TABLE 18 WORLD IRREVERSIBLE ELECTROPORATION MARKET, BY REGION, 20142022 ($MILLION)
TABLE 19 WORLD ELECTRONIC BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 20 WORLD MICROWAVE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 21 WORLD HYDROTHERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 22 WORLD LIGHT ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 23 WORLD LIGHT ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 24 WORLD COLD LASERS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 25 WORLD EXCIMER LASERS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 26 WORLD RADIATION ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 27 WORLD RADITAION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 28 WORLD BRACHYTHERAPY MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 29 WORLD BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 30 WORLD HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 31 WORLD PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 32 WORLD PERMANENT SEED BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 33 WORLD STEREOTACTIC RADIOTEHRAPY AND RADIOSURGERY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 34 WORLD IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 35 WORLD INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 36 WORLD STEREOTACTIC BODY RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 37 WORLD PROTON BEAM THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 38 WORLD ULTRASOUND ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 39 WORLD ULTRASOUND ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 40 WORLD HIFU DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 41 WORLD MRI-FUS DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 42 WORLD ULTRASONIC SURGICAL SYSTEMS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 43 WORLD SHOCK WAVE LITHOTRIPSY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 44 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 45 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 46 WORLD CRYOABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 47 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 48 WORLD TISSUE CONTACT PROBE MARKET, BY REGION, 20142022 ($MILLION)
TABLE 49 WORLD CRYOGEN SPRAY PROBE MARKET, BY REGION, 20142022 ($MILLION)
TABLE 50 WORLD EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 51 WORLD HYDROMECHANICAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 52 WORLD ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 53 WORLD CANCER ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 54 WORLD CARDIOVASCULAR ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 55 WORLD OPHTHALMOLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 56 WORLD GYNECOLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 57 WORLD UROLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 58 WORLD ORTHOPEDICS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 59 WORLD OTHER APPLICATIONS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 60 WORLD ABLATION DEVICES MARKET, BY FUNCTION, 20142022 ($MILLION)
TABLE 61 WORLD AUTOMATED/ROBOTIC ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 62 WORLD CONVENTIONAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 63 WORLD ABLATION DEVICES MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 64 WORLD AESTHETICS-SKIN REJUVENATION AND TIGHTENING ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 65 WORLD AESTHETICS-BODY SCULPTING ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 66 WORLD BENIGN PROSTATIC HYPERPLASIA ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 67 WORLD TRANSURETHRAL NEEDLE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 68 WORLD LASER AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER ABLATION/ENUCLEATION OF THE PROSTATE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 69 WORLD TRANSURETHRAL NEEDLE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 70 WORLD MENORRHAGIA/ENDOMETRIAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 71 WORLD UTERINE FIBROIDS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 72 WORLD SPINAL DECOMPRESSION AND DENERVATION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 73 WORLD VARICOSE VEINS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 74 WORLD ATRIAL FIBRILLATION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 75 WORLD TUMOR ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 76 WORLD OTHER PROCEDURES ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 77 WORLD ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 78 NORTH AMERICA ABLATION DEVICES MARKET, BY COUNTRY, 20152022 ($MILLION)
TABLE 79 NORTH AMERICA ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 80 NORTH AMERICA THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 81 NORTH AMERICA NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 82 EUROPE ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 83 EUROPE ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 84 EUROPE THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 85 EUROPE NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 86 ASIA-PACIFIC ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 87 ASIA-PACIFIC ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 88 ASIA-PACIFIC THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 89 ASIA-PACIFIC NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 90 LAMEA ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 91 LAMEA ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 92 LAMEA THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 93 LAMEA NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 94 MEDTRONIC: COMPANY SNAPSHOT
TABLE 95 MEDTRONIC: OPERATING SEGMENTS
TABLE 96 J&J: COMPANY SNAPSHOT
TABLE 97 J&J: OPERATING SEGMENTS
TABLE 98 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 99 ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 100 BOSTON: COMPANY SNAPSHOT
TABLE 101 BOSTON: OPERATING SEGMENTS
TABLE 102 ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 103 ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 104 ATRICURE: COMPANY SNAPSHOT
TABLE 105 ATRICURE: OPERATING SEGMENTS
TABLE 106 CONMED: COMPANY SNAPSHOT
TABLE 107 CONMED: OPERATING SEGMENTS
TABLE 108 OLYMPUS: COMPANY SNAPSHOT
TABLE 109 OLYMPUS: OPERATING SEGMENTS
TABLE 110 SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 111 SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 112 BTG: COMPANY SNAPSHOT
TABLE 113 BTG: OPERATING SEGMENTS
TABLE 1 CLINICAL TRIALS, ABLATION DEVICES MARKET, 20102016
TABLE 2 PATENTS REGISTERED/APPROVED, BY COUNTRY (20102016)
TABLE 3 PATENTS REGISTERED/APPROVED, BY YEAR (20102015)
TABLE 4 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
TABLE 5 WORLD ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 6 WORLD THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 7 WORLD THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 8 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 9 WORLD RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 10 WORLD TEMPERATURE CONTROLLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 11 WORLD FLUID COOLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 12 WORLD FLUID COOLED RADIOFREQUENCY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 13 WORLD ELECTRICAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 14 WORLD ELECTRICAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 15 WORLD ELECTRICAL ABLATORS MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 16 WORLD ELECTRICAL ABLATORS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 17 WORLD ARGON PLASMA/BEAM COAGULATOR MARKET, BY REGION, 20142022 ($MILLION)
TABLE 18 WORLD IRREVERSIBLE ELECTROPORATION MARKET, BY REGION, 20142022 ($MILLION)
TABLE 19 WORLD ELECTRONIC BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 20 WORLD MICROWAVE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 21 WORLD HYDROTHERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 22 WORLD LIGHT ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 23 WORLD LIGHT ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 24 WORLD COLD LASERS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 25 WORLD EXCIMER LASERS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 26 WORLD RADIATION ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 27 WORLD RADITAION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 28 WORLD BRACHYTHERAPY MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 29 WORLD BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 30 WORLD HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 31 WORLD PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 32 WORLD PERMANENT SEED BRACHYTHERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 33 WORLD STEREOTACTIC RADIOTEHRAPY AND RADIOSURGERY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 34 WORLD IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 35 WORLD INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 36 WORLD STEREOTACTIC BODY RADIATION THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 37 WORLD PROTON BEAM THERAPY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 38 WORLD ULTRASOUND ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 39 WORLD ULTRASOUND ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 40 WORLD HIFU DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 41 WORLD MRI-FUS DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 42 WORLD ULTRASONIC SURGICAL SYSTEMS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 43 WORLD SHOCK WAVE LITHOTRIPSY MARKET, BY REGION, 20142022 ($MILLION)
TABLE 44 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 45 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 46 WORLD CRYOABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 47 WORLD NON-THERMAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 48 WORLD TISSUE CONTACT PROBE MARKET, BY REGION, 20142022 ($MILLION)
TABLE 49 WORLD CRYOGEN SPRAY PROBE MARKET, BY REGION, 20142022 ($MILLION)
TABLE 50 WORLD EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 51 WORLD HYDROMECHANICAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 52 WORLD ABLATION DEVICES MARKET, BY APPLICATION, 20142022 ($MILLION)
TABLE 53 WORLD CANCER ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 54 WORLD CARDIOVASCULAR ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 55 WORLD OPHTHALMOLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 56 WORLD GYNECOLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 57 WORLD UROLOGY ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 58 WORLD ORTHOPEDICS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 59 WORLD OTHER APPLICATIONS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 60 WORLD ABLATION DEVICES MARKET, BY FUNCTION, 20142022 ($MILLION)
TABLE 61 WORLD AUTOMATED/ROBOTIC ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 62 WORLD CONVENTIONAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 63 WORLD ABLATION DEVICES MARKET, BY PROCEDURE, 20142022 ($MILLION)
TABLE 64 WORLD AESTHETICS-SKIN REJUVENATION AND TIGHTENING ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 65 WORLD AESTHETICS-BODY SCULPTING ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 66 WORLD BENIGN PROSTATIC HYPERPLASIA ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 67 WORLD TRANSURETHRAL NEEDLE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 68 WORLD LASER AND OTHER ENERGY-BASED THERAPIES/HOLMIUM LASER ABLATION/ENUCLEATION OF THE PROSTATE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 69 WORLD TRANSURETHRAL NEEDLE ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 70 WORLD MENORRHAGIA/ENDOMETRIAL ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 71 WORLD UTERINE FIBROIDS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 72 WORLD SPINAL DECOMPRESSION AND DENERVATION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 73 WORLD VARICOSE VEINS ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 74 WORLD ATRIAL FIBRILLATION ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 75 WORLD TUMOR ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 76 WORLD OTHER PROCEDURES ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 77 WORLD ABLATION DEVICES MARKET, BY REGION, 20142022 ($MILLION)
TABLE 78 NORTH AMERICA ABLATION DEVICES MARKET, BY COUNTRY, 20152022 ($MILLION)
TABLE 79 NORTH AMERICA ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 80 NORTH AMERICA THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 81 NORTH AMERICA NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 82 EUROPE ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 83 EUROPE ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 84 EUROPE THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 85 EUROPE NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 86 ASIA-PACIFIC ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 87 ASIA-PACIFIC ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 88 ASIA-PACIFIC THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 89 ASIA-PACIFIC NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 90 LAMEA ABLATION DEVICES MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 91 LAMEA ABLATION DEVICES MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 92 LAMEA THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 93 LAMEA NON-THERMAL ABLATION DEVICES MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 94 MEDTRONIC: COMPANY SNAPSHOT
TABLE 95 MEDTRONIC: OPERATING SEGMENTS
TABLE 96 J&J: COMPANY SNAPSHOT
TABLE 97 J&J: OPERATING SEGMENTS
TABLE 98 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 99 ST. JUDE MEDICAL: OPERATING SEGMENTS
TABLE 100 BOSTON: COMPANY SNAPSHOT
TABLE 101 BOSTON: OPERATING SEGMENTS
TABLE 102 ANGIODYNAMICS: COMPANY SNAPSHOT
TABLE 103 ANGIODYNAMICS: OPERATING SEGMENTS
TABLE 104 ATRICURE: COMPANY SNAPSHOT
TABLE 105 ATRICURE: OPERATING SEGMENTS
TABLE 106 CONMED: COMPANY SNAPSHOT
TABLE 107 CONMED: OPERATING SEGMENTS
TABLE 108 OLYMPUS: COMPANY SNAPSHOT
TABLE 109 OLYMPUS: OPERATING SEGMENTS
TABLE 110 SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 111 SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 112 BTG: COMPANY SNAPSHOT
TABLE 113 BTG: OPERATING SEGMENTS
LIST OF FIGURES
FIG. 1 TOP INVESTMENT POCKETS: WORLD ABLATION DEVICES MARKET, BY APPLICATION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIG. 1 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
FIG. 2 PATENTS REGISTERED/APPROVED, BY YEAR (20102015)
FIG. 3 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 U.S. ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 6 CANADA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 7 MEXICO ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 8 GERMANY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 9 FRANCE ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 10 UK ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 11 ITALY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 12 SPAIN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 13 RUSSIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 14 REST OF EUROPE ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 15 JAPAN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 16 CHINA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 17 AUSTRALIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 18 INDIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 19 SOUTH KOREA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 20 TAIWAN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 21 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 22 BRAZIL ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 23 TURKEY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 24 VENEZUELA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 25 SAUDI ARABIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 26 REPUBLIC OF SOUTH AFRICA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 27 REST OF LAMEA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 28 MEDTRONIC: REVENUE, BY YEAR ($MILLION)
FIG. 29 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
FIG. 30 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 31 J&J: REVENUE, BY YEAR ($MILLION)
FIG. 32 J&J: REVENUE, BY SEGMENT, 2015 (%)
FIG. 33 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 ST. JUDE MEDICAL: REVENUE, BY YEAR ($MILLION)
FIG. 35 ST. JUDE MEDICAL: REVENUE, BY SEGMENT, 2015 (%)
FIG. 36 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 37 BOSTON: REVENUE, BY YEAR ($MILLION)
FIG. 38 BOSTON: REVENUE, BY SEGMENT, 2015 (%)
FIG. 39 BOSTON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 40 ANGIODYNAMICS: REVENUE, BY YEAR ($MILLION)
FIG. 41 ANGIODYNAMICS: REVENUE, BY SEGMENT, 2016 (%)
FIG. 42 ANGIODYNAMICS: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 43 ATRICURE: REVENUE, BY YEAR ($MILLION)
FIG. 44 ATRICURE: REVENUE, BY SEGMENT, 2015 (%)
FIG. 45 ATRICURE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 46 CONMED: REVENUE, BY YEAR ($MILLION)
FIG. 47 CONMED: REVENUE, BY SEGMENT, 2015 (%)
FIG. 48 CONMED: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 49 OLYMPUS: REVENUE BY YEAR ($MILLION)
FIG. 50 OLYMPUS: REVENUE BY SEGMENT, 2015 (%)
FIG. 51 OLYMPUS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 52 SMITH & NEPHEW: REVENUE BY YEAR ($MILLION)
FIG. 53 SMITH & NEPHEW: REVENUE BY SEGMENT, 2015 (%)
FIG. 54 SMITH & NEPHEW: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 55 BTG: REVENUE, BY YEAR ($MILLION)
FIG. 56 BTG: REVENUE, BY SEGMENT, 2015 (%)
FIG. 57 BTG: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 1 TOP INVESTMENT POCKETS: WORLD ABLATION DEVICES MARKET, BY APPLICATION
FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (20132016)
FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2016
FIG. 1 PATENTS REGISTERED/APPROVED WORLDWIDE, 20102016
FIG. 2 PATENTS REGISTERED/APPROVED, BY YEAR (20102015)
FIG. 3 PATENTS REGISTERED/APPROVED, BY COMPANY (2010-2016)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 U.S. ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 6 CANADA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 7 MEXICO ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 8 GERMANY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 9 FRANCE ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 10 UK ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 11 ITALY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 12 SPAIN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 13 RUSSIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 14 REST OF EUROPE ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 15 JAPAN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 16 CHINA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 17 AUSTRALIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 18 INDIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 19 SOUTH KOREA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 20 TAIWAN ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 21 REST OF ASIA-PACIFIC ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 22 BRAZIL ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 23 TURKEY ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 24 VENEZUELA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 25 SAUDI ARABIA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 26 REPUBLIC OF SOUTH AFRICA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 27 REST OF LAMEA ABLATION DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 28 MEDTRONIC: REVENUE, BY YEAR ($MILLION)
FIG. 29 MEDTRONIC: REVENUE, BY SEGMENT, 2015 (%)
FIG. 30 MEDTRONIC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 31 J&J: REVENUE, BY YEAR ($MILLION)
FIG. 32 J&J: REVENUE, BY SEGMENT, 2015 (%)
FIG. 33 J&J: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 34 ST. JUDE MEDICAL: REVENUE, BY YEAR ($MILLION)
FIG. 35 ST. JUDE MEDICAL: REVENUE, BY SEGMENT, 2015 (%)
FIG. 36 ST. JUDE MEDICAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 37 BOSTON: REVENUE, BY YEAR ($MILLION)
FIG. 38 BOSTON: REVENUE, BY SEGMENT, 2015 (%)
FIG. 39 BOSTON: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 40 ANGIODYNAMICS: REVENUE, BY YEAR ($MILLION)
FIG. 41 ANGIODYNAMICS: REVENUE, BY SEGMENT, 2016 (%)
FIG. 42 ANGIODYNAMICS: REVENUE, BY GEOGRAPHY, 2016 (%)
FIG. 43 ATRICURE: REVENUE, BY YEAR ($MILLION)
FIG. 44 ATRICURE: REVENUE, BY SEGMENT, 2015 (%)
FIG. 45 ATRICURE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 46 CONMED: REVENUE, BY YEAR ($MILLION)
FIG. 47 CONMED: REVENUE, BY SEGMENT, 2015 (%)
FIG. 48 CONMED: REVENUE, BY GEOGRAPHY, 2015 (%)
FIG. 49 OLYMPUS: REVENUE BY YEAR ($MILLION)
FIG. 50 OLYMPUS: REVENUE BY SEGMENT, 2015 (%)
FIG. 51 OLYMPUS: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 52 SMITH & NEPHEW: REVENUE BY YEAR ($MILLION)
FIG. 53 SMITH & NEPHEW: REVENUE BY SEGMENT, 2015 (%)
FIG. 54 SMITH & NEPHEW: REVENUE BY GEOGRAPHY, 2015 (%)
FIG. 55 BTG: REVENUE, BY YEAR ($MILLION)
FIG. 56 BTG: REVENUE, BY SEGMENT, 2015 (%)
FIG. 57 BTG: REVENUE, BY GEOGRAPHY, 2015 (%)
